Hagen Triendl
About Hagen Triendl
Hagen Triendl is the Director of AI Research at Exscientia, where he has worked since 2021. He has a background in theoretical and mathematical physics, with postdoctoral research experience at institutions such as CERN and Imperial College London.
Current Role at Exscientia
Hagen Triendl serves as the Director of AI Research at Exscientia, a position he has held since 2021. In this role, he focuses on advancing artificial intelligence applications within the pharmaceutical industry. His work aims to enhance drug discovery processes through innovative AI methodologies.
Previous Experience at GSK
Before joining Exscientia, Hagen Triendl worked at GSK as the Director of AI/ML from 2020 to 2021. His responsibilities included leading initiatives to integrate machine learning technologies into drug development, contributing to the company's efforts in leveraging AI for improved healthcare solutions.
Postdoctoral Research at Imperial College London
Hagen Triendl was a Postdoctoral Researcher at Imperial College London from 2015 to 2018. During this period, he conducted research in theoretical and mathematical physics, contributing to various projects that explored advanced scientific concepts.
Research Background at CERN and CEA
Triendl has a solid research background, having worked as a Postdoctoral Researcher at CERN from 2013 to 2015 and at Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA) from 2010 to 2013. His experiences at these prestigious institutions involved significant contributions to projects in the field of physics.
Educational Qualifications
Hagen Triendl obtained his Doctor of Philosophy (PhD) in Theoretical and Mathematical Physics from Universität Hamburg, where he studied from 2007 to 2010. He also holds a Diplom in Physics from Heidelberg University, which he completed from 2002 to 2007. His educational background provides a strong foundation for his research and leadership roles in AI.